Genomics-based discovery of novel therapeutic drug targets requires the design of well-controlled biological or pharmacological experiments with experimental questions and hypotheses that relate to the therapeutic area of interest. This will aid the validation level of differentially expressed genes and hence facilitate the de-selection of the genes that are identified in microarray experiments. We here provide an example of how this approach is followed in the manipulation of human macrophage foam cells towards the discovery of novel drug targets for treatment of atherosclerosis.
Skip Nav Destination
Conference Article| April 01 2003
Genomics in target and drug discovery
M. van Duin ;
H. Woolson ;
D. Mallinson ;
Biochem Soc Trans (2003) 31 (2): 429–432.
- Views Icon Views
- Share Icon Share
M. van Duin, H. Woolson, D. Mallinson, D. Black; Genomics in target and drug discovery. Biochem Soc Trans 1 April 2003; 31 (2): 429–432. doi: https://doi.org/10.1042/bst0310429
Download citation file:
Don't already have an account? Register
Get Access To This Article
Buy This Article